Adma Biologics (ADMA) Gross Margin (2011 - 2026)
Adma Biologics' Gross Margin came in at 69.36% for Q2 2026, up 14.25 percentage points from 55.11% a year earlier but down 1.17 percentage points from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) Gross Margin (2011 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Adma Biologics reported Gross Margin of 64.71%, up 11.70 percentage points year-over-year; for FY2025, it came in at 57.39%, up 5.90 percentage points from FY2024.
- Gross Margin has increased in each of the last five years, with a five-year change of +102.56 percentage points (FY2020 to FY2025).
- Going back by year, Gross Margin was 51.48% in FY2024 (+17.04 pp), 34.44% in FY2023 (+11.56 pp), 22.89% in FY2022 (+21.44 pp) and 1.45% in FY2021 (+46.62 pp).
- The five-year range for quarterly Gross Margin is 1.86% (Q3 2021) to 70.53% (Q1 2026).
- Year-over-year, Gross Margin has increased for 22 consecutive quarters, with an average year-over-year change of +10.00 percentage points over the last eight quarters.
- The year-over-year gain in Gross Margin has ranged between 1.51 percentage points (Q2 2025) and 50.25 percentage points (Q4 2021) over the last five years.
- Business Quant data shows ADMA's Gross Margin at 70.53% (Q1 2026), 63.82% (Q4 2025) and 56.34% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Adma Biologics | 2.28 Bn | 1.86 Bn | 86.28 Mn | 69.36% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69.36% |
| Mar 31, 2026 | 70.53% |
| Dec 31, 2025 | 63.82% |
| Sep 30, 2025 | 56.34% |
| Jun 30, 2025 | 55.11% |
| Mar 31, 2025 | 53.22% |
| Dec 31, 2024 | 53.88% |
| Sep 30, 2024 | 49.78% |
| Jun 30, 2024 | 53.60% |
| Mar 31, 2024 | 47.77% |
| Dec 31, 2023 | 42.06% |
| Sep 30, 2023 | 36.65% |
| Jun 30, 2023 | 27.76% |
| Mar 31, 2023 | 29.01% |
| Dec 31, 2022 | 28.36% |
| Sep 30, 2022 | 23.50% |
| Jun 30, 2022 | 22.92% |
| Mar 31, 2022 | 12.58% |
| Dec 31, 2021 | 13.31% |
| Sep 30, 2021 | 1.86% |
API Access
Adma Biologics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();